Inhibitor Therapeutics Stock Performance

Inhibitor Therapeutics Relative Risk vs. Return Landscape

If you would invest  4.80  in Inhibitor Therapeutics on November 19, 2025 and sell it today you would earn a total of  1.90  from holding Inhibitor Therapeutics or generate 39.58% return on investment over 90 days. Inhibitor Therapeutics is currently generating 1.6004% in daily expected returns and assumes 16.198% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Inhibitor, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Inhibitor Therapeutics is expected to generate 21.27 times more return on investment than the market. However, the company is 21.27 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of risk.

Inhibitor Therapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Inhibitor Therapeutics has a beta of 0.78. This usually indicates as returns on the market go up, Inhibitor Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Inhibitor Therapeutics will be expected to be much smaller as well. Moreover Inhibitor Therapeutics has an alpha of 1.2686, implying that it can generate a 1.27 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Inhibitor Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Inhibitor Therapeutics. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.07 16.27 Details

Intrinsic Valuation Low Real High 0.00 0.07 16.27 Details

Inhibitor Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Inhibitor Therapeutics is not an exception. The market had few large corrections towards the Inhibitor Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Inhibitor Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Inhibitor Therapeutics within the framework of very fundamental risk indicators.

Inhibitor Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Inhibitor Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Inhibitor Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Inhibitor Therapeutics Fundamentals Growth

When running Inhibitor Therapeutics' price analysis, check to measure Inhibitor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibitor Therapeutics is operating at the current time. Most of Inhibitor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Inhibitor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibitor Therapeutics' price. Additionally, you may evaluate how the addition of Inhibitor Therapeutics to your portfolios can decrease your overall portfolio volatility.